Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Equity Ratio: 2023-2025

Historic Equity Ratio for Inhibrx Biosciences (INBX) over the last 2 years, with Sep 2025 value amounting to 0.21.

  • Inhibrx Biosciences' Equity Ratio fell 74.12% to 0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21, marking a year-over-year decrease of 74.12%. This contributed to the annual value of 0.74 for FY2024, which is 423.02% up from last year.
  • Inhibrx Biosciences' Equity Ratio amounted to 0.21 in Q3 2025, which was down 35.79% from 0.32 recorded in Q2 2025.
  • Over the past 5 years, Inhibrx Biosciences' Equity Ratio peaked at 0.85 during Q2 2024, and registered a low of 0.14 during Q4 2023.
  • In the last 3 years, Inhibrx Biosciences' Equity Ratio had a median value of 0.39 in 2025 and averaged 0.49.
  • Per our database at Business Quant, Inhibrx Biosciences' Equity Ratio soared by 423.02% in 2024 and then tumbled by 74.12% in 2025.
  • Quarterly analysis of 3 years shows Inhibrx Biosciences' Equity Ratio stood at 0.14 in 2023, then soared by 423.02% to 0.74 in 2024, then tumbled by 74.12% to 0.21 in 2025.
  • Its Equity Ratio was 0.21 in Q3 2025, compared to 0.32 in Q2 2025 and 0.39 in Q1 2025.